Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q2 2019 · 10-Q
Revenue$426.00K$426.00K+30.3% vs Q2 2018 Net Income-$1.99M-$1.99MN/M vs Q2 2018 EPS Diluted-$0.01-$0.01N/M vs Q2 2018 Gross Profit$198,000+57.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flowderived-$982,000N/M Margins · derivedGross margin46.5%+7.9 pt vs Q2 2018
Operating margin-349.1%+148.8 pt vs Q2 2018
Net margin-466.4%+634.5 pt vs Q2 2018
ended Jun 30, 2019 · filed Aug 14, 2019 · 45 d after period end